Jacob Gottlieb is considered to very good at investing in the healthcare industry. With his company, Altium Capital (AC) he is able to recognize growing companies in the healthcare industry who are making medical and health advances. He has used his education in Economics from Brown University along with studies in medicine at New York University School of Medicine to become a good business leader an entrepreneur. Gottlieb also was a portfolio manager at a company called Merlin BioMed Group (MBG). MBG was located in New York City. He was an analyst at Sanford C. Bernstein & Co., LLC (SBC). While working at SBC, Gottlieb analyzed the healthcare field.
AC has been able to invest in several companies that will help many people with their advances in medicine. Oramed Pharmaceuticals (ORMP) is one of the first companies that AC chose for an investment. AC found ORMP to be an attractive investment because of ORMP’s development that delivered insulin in a pill. The method instead of an injection would make the treatment more affordable, and it will help several people. The pill has not been approved in the United States, but it has worked well for foreign companies. AC would only take 5.6 percent investment in ORMP. AC made an investment in the company called Sellas Life Sciences (SLS). SLS is trying to develop cancer immunotherapies. It will show signals that are used to detect cancer. AC made a 9 percent stake in SLS. AC also invests in the company called Amarin. Amarin develops drugs that help cardiovascular health.
Gottlieb raises money for many philanthropic projects. Most of the projects focus on teaching youth and helping the vulnerable population. He contributes time and money to organizations such as New Yorkers for Children and East Harlem Tutorial Program. He has raised millions of dollars for a variety of causes.